Fundamental dimension Equity attribute | ENOLeader $19.32▼-1.04% Cap $163.0MP/E 4.9x QuantScore56/100 | CDZIPeer $4.34▲+6.77% Cap $367.1MP/E -8.7x QuantScore44/100 | ELLOPeer $20.62▼-1.83% Cap $284.2MP/E 4.3x QuantScore31/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
49/100 |
73/100 |
39/100 |
Valuation Multiples, PEG & DCF upside | 75/100 | 0/100 | 50/100 |
Health Piotroski, Altman Z, leverage & liquidity | 16/100 | 4/100 | 8/100 |
Growth Revenue / earnings growth & margins | 83/100 | 43/100 | 25/100 |
Sentiment Analyst ratings, targets & revisions | — | 100/100 | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 4.9x | -8.7x | 4.3x |
Forward P/E (next FY) | — | -7.8x | — |
EV / EBITDA (TTM) | 6.9x | -18.9x | 63.3x |
Price / Sales | 0.0x | 31.0x | 5.9x |
Price / Free Cash Flow | -0.2x | -11.8x | -1.9x |
PEG ratio | 0.35 | -10.13 | 0.00 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 6 / 9 | 1 / 9 | 3 / 9 |
Altman Z-Score | 0.57 (Distress) | -6.27 (Distress) | 0.36 (Distress) |
Total debt / equity | 1.90 | 25.72 | 3.16 |
Quick ratio | 0.9x | 1.0x | 1.2x |
Interest coverage | 2.0x | -5.4x | -0.0x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +9.0% | +69.8% | -16.3% |
Net income growth YoY | +66.6% | -9.6% | +67.3% |
Gross margin (TTM) | 83.9% | 27.1% | 15.1% |
Operating margin (FY) | 24.7% | -156.9% | 4.5% |
FCF margin (FY) | -21886.8% | -162.5% | -283.4% |
5. Trailing price performancePrice change over period |
1M return | -5.0% | +18.8% | -6.2% |
3M return | -7.6% | +37.2% | +6.5% |
6M return | -13.1% | -8.2% | -18.2% |
Year to date | -13.6% | -22.7% | -15.1% |
1Y return | -17.5% | -20.7% | +6.0% |
3Y return | -7.5% | +53.2% | +98.7% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $-17.12 -188.6% premium | $-37.03 -954.2% premium | $-97.00 -570.4% premium |
Wall Street consensus target | — — | $10.00 +130.7% · range $10.00–$10.00 | — — |
Consensus stance | — | 100% Buy0% Hold0% Sell | — |